(株)ヘリオスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4593/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/02/05 | 日証協 | 257,100株 | +51.77% | 27,000株 | -70.36% | 209,653株 | +27.41% | 25,900株 | -16.99% |
2016/01/29 | 日証協 | 169,400株 | -55.46% | 91,100株 | +66.85% | 164,553株 | -44.19% | 31,200株 | -6.02% |
2016/01/22 | 日証協 | 380,300株 | +5.11% | 54,600株 | +8.12% | 294,853株 | +18.68% | 33,200株 | -52.84% |
2016/01/15 | 日証協 | 361,800株 | +7.17% | 50,500株 | -51.81% | 248,453株 | +8.42% | 70,400株 | +437.36% |
2016/01/08 | 日証協 | 337,600株 | +65.33% | 104,800株 | +1996% | 229,153株 | +69.53% | 13,101株 | +43.97% |
2015/12/30 | 日証協 | 204,200株 | +1.39% | 5,000株 | +51.52% | 135,172株 | -10.41% | 9,100株 | -3.19% |
2015/12/25 | 日証協 | 201,400株 | -39.08% | 3,300株 | -96.47% | 150,873株 | -37% | 9,400株 | -21.73% |
2015/12/18 | 日証協 | 330,600株 | -3.22% | 93,500株 | +1163.51% | 239,473株 | -1.56% | 12,010株 | +93.71% |
2015/12/11 | 日証協 | 341,600株 | -1.5% | 7,400株 | -93.19% | 243,263株 | +0.25% | 6,200株 | +19.23% |
2015/12/04 | 日証協 | 346,800株 | -2.86% | 108,600株 | +113.36% | 242,663株 | -7.54% | 5,200株 | -79.86% |
2015/11/27 | 日証協 | 357,000株 | -6.45% | 50,900株 | -50.34% | 262,443株 | -14.32% | 25,820株 | +98.01% |
2015/11/20 | 日証協 | 381,600株 | +55.44% | 102,500株 | +768.64% | 306,313株 | +89.53% | 13,040株 | +26.47% |
2015/11/13 | 日証協 | 245,500株 | -31.77% | 11,800株 | -89.65% | 161,614株 | -47.19% | 10,311株 | -26.87% |
2015/11/06 | 日証協 | 359,800株 | +1.3% | 114,000株 | +909.03% | 306,003株 | +0.26% | 14,100株 | +40.83% |
2015/10/30 | 日証協 | 355,200株 | +7.93% | 11,298株 | -96.53% | 305,198株 | +10.82% | 10,012株 | -93.6% |
2015/10/23 | 日証協 | 329,100株 | +68.08% | 325,298株 | +9999.99% | 275,389株 | +52.08% | 156,505株 | +1838.14% |
2015/10/16 | 日証協 | 195,800株 | -0.41% | 2,800株 | -94.59% | 181,080株 | +2.43% | 8,075株 | -80.27% |
2015/10/09 | 日証協 | 196,600株 | +11.51% | 51,800株 | +88.36% | 176,787株 | +1.04% | 40,930株 | +207.28% |
2015/10/02 | 日証協 | 176,300株 | -23.68% | 27,500株 | +2650% | 174,975株 | -19.05% | 13,320株 | -3.48% |
※株式分割は考慮していませんのでご注意ください。
Page Top